By overexpressing ANGPT1 in MSCs, we demonstrate that genetic modification of MSCs can significantly improve the therapeutic benefits of these cells, therefore leading to a promising therapeutic approach to treat ARDS. The gene discussed is ANGPT1; the disease is acute respiratory distress syndrome.